Synonyms: CC-92480 | CC92480 | compound 4 [PMID: 32130004]
Compound class:
Synthetic organic
Comment: Mezigdomide (CC-92480) is a modulator of the E3 ubiquitin ligase cereblon (CRBN) [1]. It is an immunomodulatory therapeutic candidate for the treatment of multiple myeloma (MM), with an emphasis for lenalidomide-resistant MM. CRBN-mediated degradation of the transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) induces antitumor and immunomodulatory effects. Mezigdomide's degradion efficiency for IKZF3 is improved compared to pomalidomide and lenalidomide.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|